Edwards Lifesciences (EW) Cash from Operations Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.97% |
| Dec 31, 2025 | 2.43% |
| Sep 30, 2025 | 21.56% |
| Jun 30, 2025 | 4.64% |
| Mar 31, 2025 | 6.25% |
| Dec 31, 2024 | -18.29% |
| Sep 30, 2024 | -4.26% |
| Jun 30, 2024 | 1.72% |
| Mar 31, 2024 | -106.63% |
| Dec 31, 2023 | -14.15% |
| Sep 30, 2023 | 3.75% |
| Jun 30, 2023 | -24.85% |
| Mar 31, 2023 | 15.73% |
| Dec 31, 2022 | -4.92% |
| Sep 30, 2022 | -0.06% |
| Jun 30, 2022 | 10.94% |
| Mar 31, 2022 | 17.98% |
| Dec 31, 2021 | 13.19% |
| Sep 30, 2021 | 20.90% |
| Jun 30, 2021 | 22.55% |
| Mar 31, 2021 | 22.92% |
| Dec 31, 2020 | 30.96% |
| Sep 30, 2020 | 1.31% |
| Jun 30, 2020 | 6.34% |
| Mar 31, 2020 | 23.09% |
| Dec 31, 2019 | 34.02% |
| Sep 30, 2019 | 104.59% |
| Jun 30, 2019 | -15.20% |
| Mar 31, 2019 | -59.57% |
| Dec 31, 2018 | 21.35% |
| Sep 30, 2018 | 20.96% |
| Jun 30, 2018 | 1.82% |
| Mar 31, 2018 | 8.40% |
| Dec 31, 2017 | 25.97% |
| Sep 30, 2017 | 18.81% |
| Jun 30, 2017 | 6.13% |
| Mar 31, 2017 | 43.94% |
| Dec 31, 2016 | 16.58% |
| Sep 30, 2016 | 12.28% |
| Jun 30, 2016 | 17.63% |
| Mar 31, 2016 | 48.36% |
| Dec 31, 2015 | 2.00% |
| Sep 30, 2015 | 16.00% |
| Jun 30, 2015 | 28.79% |
| Mar 31, 2015 | 41.33% |
| Dec 31, 2014 | 7.18% |
| Sep 30, 2014 | -29.79% |